Eric Patzer's Net Worth
$26.3 Thousand
Who is Eric Patzer?
Eric Patzer does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Aridis Pharmaceuticals, Inc..
SEC CIK
Eric Patzer's CIK is 0001749992
Past Insider Trading and Trends
2023 was Eric Patzer's most active year for acquiring shares with 3 total transactions. Eric Patzer's most active month to acquire stocks was the month of April. 2020 was Eric Patzer's most active year for disposing of shares, totalling 1 transactions. Eric Patzer's most active month to dispose stocks was the month of May. 2021 saw Eric Patzer paying a total of $25,047.00 for 5,175 shares, this is the most they've acquired in one year. In 2020 Eric Patzer cashed out on 16,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aridis Pharmaceuticals, Inc. (ARDS) Snapshot price: $0.0719
Executive ChairmanEric Patzer owns 714,132 units of Common Stock which is worth $51,346.09. From 2018 to 2023 Eric Patzer acquired a total of 17,175 shares in Aridis Pharmaceuticals, Inc. at a cost of $25,047.00, Eric also disposed a total of 16,000 shares of Aridis Pharmaceuticals, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 18
| |||
Form 4
| +1.71% | 12K |
—
|
—
| 714.13K |
May 4 - Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 5
| |||
Form 4
| +0.74% | 5.17K |
$4.84 | $25,047.00 | 702.13K |
Jul 27
| |||
Form 4
| -2.24% | -16.00K |
—
|
—
| 696.96K |
Dec 22
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||